Managing Bone Health in Metastatic Breast Cancer - 100280

Spotlight
Video

Managing Bone Health in Metastatic Breast Cancer

onclivetv has 407 videos Subscribe Here

Loading........
Description: Panelists discuss their preference between denosumab (Xgeva) and zoledronic acid (Zometa), which are both currently approved to help reduce the incidence of skeletal-related events (SREs) in patients with metastatic breast cancer (MBC).

To view more from this discussion, visit http://www.onclive.com/peer...
Shared By : onclivetv
Posted on : 09/09/13
Added : 6 years ago
Category : Breast Cancer